FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma
pharmaceutical investing FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Rhabdomyosarcoma
Troy Minerals Updates on Channel Sampling at Table Mountain High-Purity Silica Project, British Columbia, Canada
Standard Uranium Confirms Strong Radioactivity at Surface During Successful Exploration Program at the Rocas Uranium Project
NevGold Discovers High-Grade Oxide Antimony "Bullet Zone" From Surface with 2025 Step-Out Drilling: 14.90 g/t AuEq Over 4.6 Meters Within 2.42 g/t AuEq Over 53.3 Meters at Limo Butte, Nevada
